Eli Lilly seeks FDA approval for weight loss drug tirzepatide ...Middle East

Pharmaceutical giant Eli Lilly is requesting fast-track approval from the Food and Drug Administration for its Type 2 diabetes medication tirzepatide to be sold as a weight loss drug. The company said that new studies have shown promising results. Nikki Battiste has more.

Hence then, the article about eli lilly seeks fda approval for weight loss drug tirzepatide was published today ( Friday 28/04/2023 - 02:45 AM ) and is available on CBS News ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Eli Lilly seeks FDA approval for weight loss drug tirzepatide )

Also on site :

• The bean boom isn’t over – and these five recipes prove why they’re perfect for Veganuary
• Run Away review – James Nesbitt brings much-needed heft to this Harlan Coben hokum
• Tom Hiddleston welcomes second baby with partner Zawe Ashton